Panel Business of Biotech track
Navigating partnering and business development in a shifting global landscape
Mon, Nov 9, 2026 · 1:00–2:00 PM CET Business of Biotech Stage, Koelnmesse
About this session
As the biotech and pharma sectors enter a pivotal year marked by rapid scientific breakthroughs, evolving regulatory landscapes, and shifting economic pressures, dealmaking remains the steady anchor amid unpredictable market tides. This session unravels the forces shaping the future of biopharma partnerships and M&A in 2026, including the financing climate, emerging therapeutic trends, and geopolitical factors influencing cross-border transactions.
Speakers
-
VP Global Sales and Marketing, Full-Service Commercialization · Syneos Health
Moderator
-
Executive Director, Head of Scouting & Transaction, Primary Focus Genetic Regulation/Blindness & Regeneration · Astellas
Panelist
